BioXcel Therapeutics, Inc. (BTAI)
1.61
-0.04
(-2.42%)
USD |
NASDAQ |
Mar 05, 16:00
1.55
-0.06
(-3.73%)
After-Hours: 20:00
BioXcel Therapeutics Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | -25.36M |
| Puma Biotechnology, Inc. | -26.98M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | 21.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.79M |
| Cash from Financing (Quarterly) | 37.53M |
| Free Cash Flow | -58.21M |
| Free Cash Flow Per Share (Quarterly) | -1.323 |
| Free Cash Flow to Equity (Quarterly) | -19.13M |
| Free Cash Flow to Firm (Quarterly) | -14.41M |
| Free Cash Flow Yield | -483.5% |